Hyperfine, Inc. (HYPR)
| Market Cap | 109.23M |
| Revenue (ttm) | 10.80M |
| Net Income (ttm) | -39.36M |
| Shares Out | 78.58M |
| EPS (ttm) | -0.53 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 417,131 |
| Open | 1.440 |
| Previous Close | 1.410 |
| Day's Range | 1.370 - 1.460 |
| 52-Week Range | 0.533 - 1.900 |
| Beta | 1.07 |
| Analysts | Strong Buy |
| Price Target | 1.28 (-7.91%) |
| Earnings Date | Nov 11, 2025 |
About HYPR
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredi... [Read more]
Financial Performance
In 2024, Hyperfine's revenue was $12.89 million, an increase of 16.84% compared to the previous year's $11.03 million. Losses were -$40.72 million, -7.95% less than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for HYPR stock is "Strong Buy." The 12-month stock price target is $1.28, which is a decrease of -7.91% from the latest price.
News
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software.
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Co...
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered p...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine hits 100-patient milestone in portable MRI study, accelerating access to brain imaging in neurology clinics with next-gen Swoop® system.
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--First patients enrolled in PRIME study at Yale School of Medicine, aiming to evaluate the potential of AI-powered portable MRI tech in the ED setting.
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference
TORONTO--(BUSINESS WIRE)--Swoop® AI-powered portable MRI system shows 100% sensitivity for ARIA-E detection in Lecanemab patients (CARE PMR study data presented at AAIC 2025).
Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care
GUILFORD, Conn.--(BUSINESS WIRE)--New studies showcase the Swoop® MRI system's potential role in expanding access to dementia care and monitoring Alzheimer's treatment.
Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine begins commercial launch of Optive AI™ software, bringing substantial image quality improvements to Swoop® systems.
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces first sales of next-gen Swoop® MRI system, powered by Optive AI™ software, to top U.S. hospitals following FDA clearance.
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine appoints Rob Fasciano, PhD, and Rafael O'Halloran, PhD, to help advance AI-powered MRI technology and scale next-gen imaging solutions.
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
GUILFORD, Conn.--(BUSINESS WIRE)--FDA clears next-gen Swoop® MRI system with Optive AI™ software, bringing a transformative leap in image quality with enhanced usability and comfort.
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable M...
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Bret...
Hyperfine, Inc. Reports First Quarter 2025 Financial Results
GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered po...
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (...
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett H...
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable
Hyperfine, Inc. HYPR shares are surging on Monday. Hyperfine collaborates with Nvidia to advance portable MRI technology. The partnership aims to improve image quality and reduce scan times.
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025.
Hyperfine Announces $6.0 Million Registered Direct Offering
GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and...
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis.